These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 24284413)
1. Efficacy of hepatitis A vaccination and factors impacting on seroconversion in patients with inflammatory bowel disease. Park SH; Yang SK; Park SK; Kim JW; Yang DH; Jung KW; Kim KJ; Ye BD; Byeon JS; Myung SJ; Kim JH Inflamm Bowel Dis; 2014 Jan; 20(1):69-74. PubMed ID: 24284413 [TBL] [Abstract][Full Text] [Related]
2. Immunogenecity of hepatitis A and B vaccination in pediatric patients with inflammatory bowel disease. Urganci N; Kalyoncu D J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):412-15. PubMed ID: 23841120 [TBL] [Abstract][Full Text] [Related]
3. Immunogenecity of hepatitis A vaccine in pediatric patients with inflammatory bowel disease. Radzikowski A; Banaszkiewicz A; Łazowska-Przeorek I; Grzybowska-Chlebowczyk U; Woś H; Pytrus T; Iwańczak B; Kowalska-Duplaga K; Fyderek K; Gawrońska A; Karolewska-Bochenek K; Kotowska M; Albrecht P Inflamm Bowel Dis; 2011 May; 17(5):1117-24. PubMed ID: 20818674 [TBL] [Abstract][Full Text] [Related]
4. Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. Fiorino G; Peyrin-Biroulet L; Naccarato P; Szabò H; Sociale OR; Vetrano S; Fries W; Montanelli A; Repici A; Malesci A; Danese S Inflamm Bowel Dis; 2012 Jun; 18(6):1042-7. PubMed ID: 21674732 [TBL] [Abstract][Full Text] [Related]
5. Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients. Andrade P; Santos-Antunes J; Rodrigues S; Lopes S; Macedo G J Gastroenterol Hepatol; 2015 Nov; 30(11):1591-5. PubMed ID: 25967740 [TBL] [Abstract][Full Text] [Related]
6. Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants. Andrisani G; Frasca D; Romero M; Armuzzi A; Felice C; Marzo M; Pugliese D; Papa A; Mocci G; De Vitis I; Rapaccini GL; Blomberg BB; Guidi L J Crohns Colitis; 2013 May; 7(4):301-7. PubMed ID: 22673636 [TBL] [Abstract][Full Text] [Related]
7. SEROCONVERSION ANALYSIS AFTER HABITUAL HEPATITIS B VACCINATION SCHEME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES. Cunha IS; Silva TCD; Malluta ÉF; Scolaro BL; Velho PS; Stall J Arq Gastroenterol; 2020; 57(1):69-73. PubMed ID: 32294738 [TBL] [Abstract][Full Text] [Related]
8. [The seroprevalence rate, vaccination rate and seroconversion rate of hepatitis A in central region of Korea]. Yun SW; Lee WK; Cho SY; Moon SH; Shin HD; Yun SY; Kim SB; Shin JE; Kim HJ; Song IH; Lee KS; Lee JH Korean J Gastroenterol; 2011 Mar; 57(3):166-72. PubMed ID: 21519164 [TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus-infected and -uninfected men who have sex with men. Tseng YT; Chang SY; Liu WC; Sun HY; Wu CH; Wu PY; Lu CL; Hung CC; Chang SC Hepatology; 2013 May; 57(5):1734-41. PubMed ID: 23258666 [TBL] [Abstract][Full Text] [Related]
10. Kinetics of anti-hepatitis B surface antigen titers after hepatitis B vaccination in patients with inflammatory bowel disease. Gisbert JP; Villagrasa JR; Rodríguez-Nogueiras A; Chaparro M Inflamm Bowel Dis; 2013 Mar; 19(3):554-8. PubMed ID: 23380936 [TBL] [Abstract][Full Text] [Related]
11. The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination. Melgaço JG; Pinto MA; Rocha AM; Freire M; Gaspar LP; Lima SM; Cruz OG; Vitral CL J Med Virol; 2011 Feb; 83(2):208-17. PubMed ID: 21181914 [TBL] [Abstract][Full Text] [Related]
12. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community. Barkai G; Belmaker I; Givon-Lavi N; Dagan R Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain. Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196 [TBL] [Abstract][Full Text] [Related]
14. Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents. Pham HV; Hasan I; Udaltsova N; Pham K; Abramson O; Armstrong MA; Postlethwaite D; Li D Dig Dis Sci; 2018 Jan; 63(1):209-217. PubMed ID: 28836068 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children. Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917 [TBL] [Abstract][Full Text] [Related]
16. Decline of maternal hepatitis A virus antibody levels in infants. De Silvestri A; Avanzini MA; Terulla V; Zucca S; Polatti F; Belloni C Acta Paediatr; 2002; 91(8):882-4. PubMed ID: 12222709 [TBL] [Abstract][Full Text] [Related]
17. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis A vaccine response in HIV-infected patients: are TWINRIX and HAVRIX interchangeable? Jimenez HR; Hallit RR; Debari VA; Slim J Vaccine; 2013 Feb; 31(9):1328-33. PubMed ID: 23277097 [TBL] [Abstract][Full Text] [Related]
19. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India? Anand AC; Nagpal AK; Seth AK; Dhot PS J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C. Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]